Tufts receives patent for antibody treatment against hemolytic uremic syndrome
Monday, February 28, 2011 - 17:01
in Health & Medicine
Researchers at the Cummings School of Veterinary Medicine have received U.S. patent approval for an antibody-based treatment for Hemolytic Uremic Syndrome (HUS), a potentially fatal outcome of E. coli poisoning and the leading cause of kidney failure in children.